Search
Now showing items 1-10 of 11
Article
Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARSCoV- 2 variants with high potency
| Date Issued:
2021 | Copyright:
open access
Article
Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
| Date Issued:
2021 | Copyright:
open access
Article
SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites
| Date Issued:
2021 | Copyright:
open access
Article
Non-permissive SARS-CoV-2 infection in human neurospheres
| Date Issued:
2021 | Copyright:
open access
Article
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
| Date Issued:
2021 | Copyright:
open access
Article
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
| Date Issued:
2017 | Copyright:
open access
Article
Genetic evidence and host immune response in persons reinfected with SARS-CoV-2, Brazil
| Date Issued:
2021 | Copyright:
open access
Article
Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation
| Date Issued:
2023 | Copyright:
open access
Article
Aureonitol, a Fungi-Derived Tetrahydrofuran, Inhibits Influenza Replication by Targeting Its Surface Glycoprotein Hemagglutinin
| Date Issued:
2015 | Copyright:
open access
Article
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
| Date Issued:
2020 | Copyright:
open access